These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8381382)

  • 1. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors.
    Romeo JM; Ulrich PP; Busch MP; Vyas GN
    Hepatology; 1993 Feb; 17(2):188-95. PubMed ID: 8381382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
    McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
    Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival.
    Wright TL; Hollander H; Pu X; Held MJ; Lipson P; Quan S; Polito A; Thaler MM; Bacchetti P; Scharschmidt BF
    Hepatology; 1994 Nov; 20(5):1152-5. PubMed ID: 7927246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and outcome of hepatitis C infection among heart transplant recipients.
    Zein NN; McGreger CG; Wendt NK; Schwab K; Mitchell PS; Persing DH; Rakela J
    J Heart Lung Transplant; 1995; 14(5):865-9. PubMed ID: 8800721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers].
    Aymard JP; Botte C; Contal P; Janot C; Streiff F
    Pathol Biol (Paris); 1993 Feb; 41(2):149-53. PubMed ID: 8327265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent and new hepatitis C virus infection after liver transplantation.
    Everhart JE; Wei Y; Eng H; Charlton MR; Persing DH; Wiesner RH; Germer JJ; Lake JR; Zetterman RK; Hoofnagle JH
    Hepatology; 1999 Apr; 29(4):1220-6. PubMed ID: 10094968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step RNA polymerase chain reaction for detection of hepatitis C virus RNA.
    Hu KQ; Yu CH; Vierling JM
    Hepatology; 1993 Aug; 18(2):270-4. PubMed ID: 7687979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hepatitis C virus infection in Niger: comparative evaluation of second generation ELISA screening tests and tests of confirmation].
    De Groof D; Michielsen P; Hassane A; Leyssens N; Ramon A; Pelckmans P
    Gastroenterol Clin Biol; 1996; 20(3):320-2. PubMed ID: 8763077
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C viral RNA amplification by the polymerase chain reaction allows detection of false positive HCV ELISAs among patients with non-A, non-B hepatitis.
    Rodríguez-Medina JR; Carrasquillo EA; Sarriera JE; Medina R; Oharriz JJ; Rubio CE
    P R Health Sci J; 1993 Apr; 12(1):35-8. PubMed ID: 8390064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.